Myriad Genetics (MYGN) stock is downgraded from a "Buy" to "Hold" due to flat Q3 2025 earnings and limited near-term revenue ...

The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both ...

With almost all of its citizens’ genes already sequenced in a national database, it’s the test case for an ambitious—and, to ...

Rising demand for early genetic screenings, technological advancements, and increased awareness are key growth drivers. With ...

The first surgery in a clinical trial testing the safety and efficacy of gene-edited pig kidney transplants in patients with ...

RNZ went with Biosecurity staff to Kaipātiki Park in Glenfield where they'd placed four bait traps. They all contained a ...

Aileen Lopera filed a paternity suit against Diggs in December 2024, just months before welcoming their daughter.

Aileen Lopera filed a paternity suit against Diggs in December 2024, just months before welcoming their daughter.

A new deep learning framework can accurately classify four molecular subgroups of medulloblastoma and predict critical ...

Nearly half of all women aged younger than 40 who live with advanced breast cancer have children under the age of 18, ...

Q3 2025 Earnings Call Transcript November 4, 2025 SOPHiA GENETICS S.A. misses on earnings expectations. Reported EPS is $-0.3 ...

Rochester Regional Health has launched GenoWell, a free genetic screening initiative with Helix to help more than 100,000 ...